Celleron Therapeutics, the UK-based company and Oxford University spin-out developing personalised medicine for cancer patients, has today announced the initiation and first patient enrolment of its clinical study that will evaluate the effect of a novel combination therapy approach for colorectal cancer. Professor Mark Middleton, Consultant Medical Oncologist and Professor of Experimental Cancer Medicine at […]
About Oxford Centre
This author has yet to write their bio.Meanwhile lets just say that we are proud Oxford Centre contributed a whooping 75 entries.
Entries by Oxford Centre
A pioneering study into myeloma, a rare cancer, could lead to GPs using simple blood tests to improve early diagnosis. CRUK Centre members, in collaboration with the University of Exeter and Chiddenbrook Surgery, Crediton, found that a simple combination of blood tests, which are routinely conduced in GP surgeries, could improve early diagnosis of myeloma. […]
A team of Cancer Centre researchers lead by Associate Professor Ross Chapman have discovered a novel DNA repair protein complex called ‘Shieldin’. Published in Nature, the paper describes the identification of ‘Shieldin’, which was shown to be essential for generating genetic diversity in antibodies produced during immune responses. When activated following an infection or immunisation, B […]
Researchers have made a breakthrough in more precisely targeting drugs to cancers. A number of Centre members were part of a multi-disciplinary team of biomedical engineers, oncologists, radiologists and anaesthetists that have used ultrasound and lipid drug carriers (liposomes) to improve the targeting of cancer drugs to a tumour. The new technology has been used […]
In a collaboration spanning multiple departments within Oxford and beyond, Centre members led by Dr Ioannis Psallidas have developed a new risk score (PROMISE score) that can provide important information on patient prognosis, and guide the selection of appropriate management strategies for patients with malignant pleural effusion. Malignant pleural effusion is defined as the accumulation […]
Results of the AspECT clinical trial, coordinated by the CRUK Oxford Centre supported Oncology Clinical Trials Office, have shown the important role aspirin and acid reflux treatment can have in preventing those at high risk of oesophageal cancer from going on to develop the disease. The trial led by Professor Janusz Jankowski had results presented […]
New initiative with the Synthetic Biology CDT
The Centre is pleased to announce the appointment of Professor Xin Lu as Co-Director of the Centre.
Today at the NCRI Annual Conference Professor Simon Leedham was awarded the Cancer Research UK Future Leaders in Cancer Research Prize. Simon is a Cancer Research UK Clinician Scientist Fellow at the Wellcome Trust Centre for Human Genetics. His research has made important advances in the cell biology and molecular pathogenesis of gastrointestinal cancers and […]
Professor Nicola Sibson of the Department of Oncology has been awarded a grant worth almost £200,000 by research charity Breast Cancer Now to fund cutting-edge research to uncover novel treatment combinations to control breast cancer that has spread to the brain.
- Pioneering Combination Therapy Approach to Treating Colorectal CancerAugust 20, 2018 - 11:11 am
- Rare cancer could be caught early using simple blood testsAugust 16, 2018 - 1:30 pm
- Oxford researchers discover DNA repair protein complex important in drug resistance in cancers driven by BRCA mutations.August 9, 2018 - 10:22 am